Androgen Deprivation Therapy (ADT), a standard intervention for advanced Prostate Cancer (PCa), could effectively reduce androgen levels or block androgen receptor signaling, effectively suppressing tumor growth and progression. Here, AR is linked to prostate carcinoma.